Cyclosporin pro-dispersion liposphere formulation

Journal of Controlled Release

Volumn 160, Issue 2, 2012, Pages 401-406

  Avramoff, Avi ^a   Khan, Wahid ^a   Ezra, Aviva ^a   Elgart, Anna ^a   Hoffman, Amnon ^a   Domb, Abraham J ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cyclosporin; Hydrophobic drug; Liposphere; Oral delivery; Pro dispersion

Indexed keywords

CYCLOSPORIN; HYDROPHOBIC DRUG; LIPOSPHERE; ORAL DELIVERY; PRO-DISPERSION;

BIOCHEMISTRY; CENTRIFUGATION; MICROEMULSIONS; ORGANIC SOLVENTS; PHOSPHOLIPIDS; SURFACE ACTIVE AGENTS;

DISPERSIONS;

AMPHOPHILE; CYCLOSPORIN A; FAT; LIPOSPHERE; MICROSPHERE; ORGANIC SOLVENT; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYOELECTRON MICROSCOPY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; MICROEMULSION; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION;

BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CRYOELECTRON MICROSCOPY; CYCLOSPORINE; DRUG CARRIERS; DRUG COMPOUNDING; IMMUNOSUPPRESSIVE AGENTS; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; SOLUBILITY; SURFACE PROPERTIES; TRIGLYCERIDES;

EID: 84861679684     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.12.016     Document Type: Article

References (16)

1. J.L. Italia, V. Bhardwaj, and M.N. Kumar Disease, destination, dose and delivery aspects of ciclosporin: the state of the art Drug Discov. Today 11 17-18 2006 846 854
2. A. Maza, H. Montaudie, E. Sbidian, A. Gallini, S. Aractingi, F. Aubin, H. Bachelez, B. Cribier, P. Joly, D. Jullien, M. Le Maitre, L. Misery, M.A. Richard, J.P. Ortonne, and C. Paul Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis J. Eur. Acad. Dermatol. Venereol. 25 Suppl. 2 2011 19 27
3. C.D. Boubouka, C. Charissi, D. Kouimintzis, D. Kalogeromitros, P.G. Stavropoulos, and A. Katsarou Treatment of autoimmune urticaria with low-dose cyclosporin A: a one-year follow-up Acta Derm. Venereol. 91 1 2011 50 54
4. C.A. Utine, M. Stern, and E.K. Akpek Clinical review: topical ophthalmic use of cyclosporin A Ocul. Immunol. Inflamm. 18 5 2010 352 361
5. N. el Tayar, A.E. Mark, P. Vallat, R.M. Brunne, B. Testa, and W.F. van Gunsteren Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations J. Med. Chem. 36 24 1993 3757 3764
6. P.R. Beauchesne, N.S. Chung, and K.M. Wasan Cyclosporine A: a review of current oral and intravenous delivery systems Drug Dev. Ind. Pharm. 33 3 2007 211 220
7. J.M. Kovarik, E.A. Mueller, J.B. van Bree, W. Tetzloff, and K. Kutz Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation J. Pharm. Sci. 83 3 1994 444 446
8. T. Andrysek Impact of physical properties of formulations on bioavailability of active substance: current and novel drugs with cyclosporine Mol. Immunol. 39 17-18 2003 1061 1065
9. X.Q. Wang, J.D. Dai, Z. Chen, T. Zhang, G.M. Xia, T. Nagai, and Q. Zhang Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration J. Control. Release 97 3 2004 421 429
10. J. Molpeceres, M. Guzman, M.R. Aberturas, M. Chacon, and L. Berges Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement J. Pharm. Sci. 85 2 1996 206 213
11. A. Saez, M. Guzman, J. Molpeceres, and M.R. Aberturas Freeze-drying of polycaprolactone and poly(d, l-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs Eur. J. Pharm. Biopharm. 50 3 2000 379 387
12. M.H. El-Shabouri Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A Int. J. Pharm. 249 1-2 2002 101 108
13. D.B. Masters, and A.J. Domb Liposphere local anesthetic timed-release for perineural site application Pharm. Res. 15 7 1998 1038 1045
14. A. Avramoff, A. Laor, R. Kitzes-Cohen, D. Farin, and A.J. Domb Comparative in vivo bioequivalence and in vitro dissolution of two cyclosporin A soft gelatin capsule formulations Int. J. Clin. Pharmacol. Ther. 45 2 2007 126 132
15. C. Demetzos Differential Scanning Calorimetry (DSC): a tool to study the thermal behavior of lipid bilayers and liposomal stability J. Liposome Res. 18 3 2008 159 173
16. S.C. Gad, C.D. Cassidy, N. Aubert, B. Spainhour, and H. Robbe Nonclinical vehicle use in studies by multiple routes in multiple species Int. J. Toxicol. 25 6 2006 499 521